Open AccessEffect of Mass Distribution of Azithromycin for Trachoma Control on Overall Mortality in Ethiopian Children
Author(s) -
Travis C. Porco,
Teshome Gebre,
Berhan Ayele,
Jenafir House,
Jeremy D. Keenan,
Zhaoxia Zhou,
Kevin C. Hong,
Nicole E. Stoller,
Kathryn J. Ray,
Paul M. Emerson,
Bruce D. Gaynor,
Thomas M. Lietman
Publication year - 2009
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2009.1266
Subject(s) - azithromycin , trachoma , medicine , randomized controlled trial , pediatrics , context (archaeology) , chlamydia , antibiotics , immunology , paleontology , pathology , microbiology and biotechnology , biology
Mass oral azithromycin distribution to affected communities is a cornerstone of the World Health Organization's trachoma elimination program. Antibiotics are provided to target the ocular strains of chlamydia that cause trachoma, but may also be efficacious against respiratory disease, diarrhea, and malaria--frequent causes of childhood mortality in trachoma-endemic areas.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom